best health software glp-1 alerts 2025 trends 2025: real-world data, patient outcomes & future therapies GLP-1s in 2025: Who's Using
Description
As a health coach, I compare the pros & cons of these weight loss options
Methods Adults with T2D treated with 2 glucose-lowering agents who initiated GLP-1 RAs or basal insulin from 2010 to 2019 were propensity-score matched (1:1) and followed until October 2021 (intention-to-treat [ITT])
GLP-1 medications, including Ozempic, Wegovy, Mounjaro and Zepbound, have reshaped treatment for millions of Americans living with type 2 diabetes and managing weight
Financial Results and Expansion: Sigmas first-quarter sales up 17%, retail network sales up 14.7% year-over-year
Find out if Aetna covers Mounjaro or other GLP-1 weight loss injections
